Variant report
Variant | nsv824661 |
---|---|
Chromosome Location | chr8:62035336-62035913 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541567809 | chr8:62035381-62035382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559719876 | chr8:62035388-62035389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575043668 | chr8:62035441-62035442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149087032 | chr8:62035460-62035461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113720594 | chr8:62035509-62035510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181955896 | chr8:62035528-62035529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145913952 | chr8:62035553-62035554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138971442 | chr8:62035599-62035600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564560522 | chr8:62035619-62035620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11988706 | chr8:62035644-62035645 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs528600342 | chr8:62035653-62035654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186085107 | chr8:62035688-62035689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189887566 | chr8:62035689-62035690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529872577 | chr8:62035725-62035726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200373939 | chr8:62035744-62035745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62524520 | chr8:62035751-62035752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113571942 | chr8:62035760-62035761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569662503 | chr8:62035765-62035766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536608728 | chr8:62035766-62035767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373398478 | chr8:62035782-62035783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551141461 | chr8:62035783-62035784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72372640 | chr8:62035831-62035832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4099520 | chr8:62035833-62035834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28414183 | chr8:62035836-62035837 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs534436479 | chr8:62035839-62035840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553067774 | chr8:62035842-62035843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs58959777 | chr8:62035856-62035857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs386508516 | chr8:62035892-62035893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:62034000-62037000 | Enhancers | GM12878-XiMat | blood |
2 | chr8:62034200-62035600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr8:62034400-62035400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr8:62034400-62051400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:62035000-62035400 | Enhancers | Fetal Brain Male | brain |
6 | chr8:62035000-62036200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr8:62035200-62036200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:62035400-62036400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:62035600-62036000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |